Evidence map›Paper›PMID 42801338›Full record

ArticleExperimental brain research2026

The effects of increasing and decreasing dopamine on inhibition of return: a psychopharmacological investigation.

Grace A Whitaker, Ellen Poliakoff, Sarah L Martin, Joanna C Neill, Monty Silverdale, Christopher Kobylecki, Wael El-Deredy

Abstract read
In one paragraph

Article in Experimental brain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Grace A WhitakerDepartment of Electronic Engineering and Advanced Center for Electrical and Electronic Engineering, Universidad Técnica Federico Santa Maria, Valparaiso, Chile. grace.whitaker@usm.cl.
Ellen PoliakoffAndrew Mayes Centre for Cognitive Neuroscience, Division of Psychology, Communication and Human Neuroscience, The University of Manchester, Manchester, UK.
Sarah L MartinTranslational and Computational Neurosciences Unit, Department of Psychology, Faculty of Health & Education, Manchester Metropolitan University, Manchester, UK.
Joanna C NeillDivision of Pharmacy & Optometry, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, School of Health Sciences, University of Manchester, Manchester, UK.
Monty SilverdaleDepartment of Neurology, Manchester Academic Health Science Centre, Salford Royal Foundation Trust, University of Manchester, Manchester, UK.
Christopher KobyleckiDepartment of Neurology, Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Wael El-DeredyBrain Dynamics Lab, Interdisciplinary Center of Biomedical and Engineering Research for Health, Universidad de Valparaíso, Valparaíso, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibition of Return (IOR) is the phenomenon of being slower to re-attend to previously attended locations, and is thought to improve the efficiency of attention. Previous studies of dopaminergic disorders indicate that excessive or insufficient dopamine signaling in the striatum of the brain reduces IOR magnitude. However, there have been no studies of the direct effects of dopamine depletion on IOR in healthy individuals, or that have compared the effect of dopamine increases and decreases within the same population. Therefore, in the present study, we administered a selective dopamine-2 receptor (D2R) agonist and antagonist to the same healthy participants (cabergoline and amisulpride, respectively) and measured IOR. We further investigated the effects of dopamine manipulation on the underlying cognitive processes of IOR using event-related potentials. Both manipulations reduced the IOR effect relative to placebo, consistent with a non-linear relationship between dopamine and IOR. Given the D2R selectivity of both drugs and the accompanying changes in eye-blink rate, these effects are likely driven by primarily striatal dopamine, potentially reflecting frontostriatal modulation of the balance between attentional flexibility and stability.

Indexed as

AttentionDopamineDopamine AgonistsEvoked PotentialsInhibition, PsychologicalAdultAmisulprideDopamine AntagonistsDouble-Blind MethodElectroencephalographyFemaleHumansMaleReaction TimeReceptors, Dopamine D2SulpirideAmisulprideDopamineDopamine AgonistsDopamine AntagonistsReceptors, Dopamine D2SulpirideAttentional mechanismsD2-receptorsDopamineInhibition of returnStriatum

Identifiers

PMID42801338
PMCPMC13616838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.